- Home
- SPRY vs KBDC Comparison
SPRY vs KBDC Comparison
Compare SPRY & KBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- KBDC
- Stock Information
- Founded
- SPRY 2015
- KBDC 2021
- Country
- SPRY United States
- KBDC United States
- Employees
- SPRY N/A
- KBDC N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- KBDC
- Sector
- SPRY Health Care
- KBDC
- Exchange
- SPRY Nasdaq
- KBDC Nasdaq
- Market Cap
- SPRY 1.8B
- KBDC 1.1B
- IPO Year
- SPRY N/A
- KBDC N/A
- Fundamental
- Price
- SPRY $9.41
- KBDC $14.25
- Analyst Decision
- SPRY Strong Buy
- KBDC Buy
- Analyst Count
- SPRY 5
- KBDC 4
- Target Price
- SPRY $31.00
- KBDC $16.50
- AVG Volume (30 Days)
- SPRY 3.1M
- KBDC 225.6K
- Earning Date
- SPRY 11-12-2025
- KBDC 11-12-2025
- Dividend Yield
- SPRY N/A
- KBDC 13.30%
- EPS Growth
- SPRY N/A
- KBDC N/A
- EPS
- SPRY N/A
- KBDC N/A
- Revenue
- SPRY $112,339,000.00
- KBDC N/A
- Revenue This Year
- SPRY N/A
- KBDC $193.84
- Revenue Next Year
- SPRY $182.40
- KBDC $7.11
- P/E Ratio
- SPRY N/A
- KBDC N/A
- Revenue Growth
- SPRY 22367.80
- KBDC N/A
- 52 Week Low
- SPRY $9.39
- KBDC $13.93
- 52 Week High
- SPRY $18.90
- KBDC $17.99
- Technical
- Relative Strength Index (RSI)
- SPRY 44.82
- KBDC 23.98
- Support Level
- SPRY N/A
- KBDC $15.00
- Resistance Level
- SPRY $10.78
- KBDC $15.47
- Average True Range (ATR)
- SPRY 0.65
- KBDC 0.23
- MACD
- SPRY -0.43
- KBDC -0.06
- Stochastic Oscillator
- SPRY 67.22
- KBDC 3.17
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About KBDC Kayne Anderson BDC Inc. Common Stock
Kayne Anderson BDC Inc is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company that invests primarily in first-lien senior secured loans, with a secondary focus on unitranche and split-lien loans to middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through debt investments in middle-market companies.